Inter Pharma PCL (BKK: IP)

Inter Pharma PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	310.06	412.39	776.42	173.87	152.33	342.65
Short-Term Investments	0.87	0.86	0.83	0.8	0.77	0.19
Cash & Short-Term Investments	310.92	413.25	777.25	174.67	153.09	342.84
Cash Growth	-42.18%	-46.83%	344.99%	14.09%	-55.35%	950.73%
Accounts Receivable	301.7	337.32	340.3	258.11	124.38	102.67
Other Receivables	97.63	87.74	51.89	34.08	31.49	1.9
Receivables	399.33	425.06	392.2	292.25	155.93	104.63
Inventory	350.05	351.82	332.98	192	107.65	51.43
Prepaid Expenses	-	-	-	-	-	5.66
Other Current Assets	9.77	12.72	12.78	7.7	0.61	0.5
Total Current Assets	1,070	1,203	1,515	666.61	417.28	505.05
Property, Plant & Equipment	976.54	929.27	880.77	457.32	255.39	9.67
Long-Term Investments	42.69	43.37	9.35	10.12	-	4.61
Goodwill	477.85	477.85	477.85	22.16	22.16	-
Other Intangible Assets	209.19	197.36	167.79	55.1	48.58	1.28
Long-Term Deferred Tax Assets	16.17	15.91	9.81	8.98	3.38	3.26
Other Long-Term Assets	91.92	85.75	29.52	106.76	9.5	1.89
Total Assets	2,884	2,952	3,090	1,327	756.33	525.88
Accounts Payable	183.87	200.52	193.79	69.65	58.49	17.14
Accrued Expenses	47.63	47.06	34.74	15.92	11.69	7.69
Short-Term Debt	16.13	46.34	48.73	131.01	11.01	9.23
Current Portion of Long-Term Debt	52.71	54.43	72.51	35.62	15.53	-
Current Portion of Leases	31.67	38.89	30.46	0.57	0.64	-
Current Income Taxes Payable	6.16	4.11	25.18	14.8	8.4	5.35
Other Current Liabilities	91.54	87.39	92.55	68.06	54.58	16.82
Total Current Liabilities	429.7	478.75	497.95	335.63	160.35	56.23
Long-Term Debt	179.06	205.46	319.61	187.06	90.91	-
Long-Term Leases	54.35	54.83	67.69	1.9	2.47	-
Long-Term Deferred Tax Liabilities	59.78	59.21	55.33	3.53	7.62	-
Other Long-Term Liabilities	5.27	3.66	2.14	-	-	-
Total Liabilities	763.83	834.65	973.86	543.54	269.89	60.13
Common Stock	302.67	186.26	186.26	149.01	103	103
Additional Paid-In Capital	1,498	1,498	1,498	492.09	304.98	304.98
Retained Earnings	115.09	225.25	238.26	116.85	58.16	44.02
Comprehensive Income & Other	3.7	3.7	3.7	3.7	3.7	3.7
Total Common Equity	1,919	1,913	1,926	761.64	469.85	455.71
Minority Interest	201.17	204.53	190.25	21.86	16.59	10.03
Shareholders' Equity	2,121	2,118	2,116	783.5	486.44	465.74
Total Liabilities & Equity	2,884	2,952	3,090	1,327	756.33	525.88
Total Debt	333.92	399.95	539	356.17	120.57	9.23
Net Cash (Debt)	-22.99	13.3	238.25	-181.5	32.53	333.61
Net Cash Growth	-	-94.42%	-	-	-90.25%	1496.82%
Net Cash Per Share	-0.04	0.02	0.45	-0.38	0.07	0.94
Filing Date Shares Outstanding	605.34	605.35	605.35	484.27	468.65	468.65
Total Common Shares Outstanding	605.34	605.35	605.35	484.27	468.65	468.65
Working Capital	640.38	724.1	1,017	330.98	256.93	448.82
Book Value Per Share	3.17	3.16	3.18	1.57	1.00	0.97
Tangible Book Value	1,232	1,238	1,281	684.38	399.11	454.43
Tangible Book Value Per Share	2.04	2.05	2.12	1.41	0.85	0.97
Land	-	327.63	327.63	183.25	117.3	-
Buildings	-	430.08	404.55	177.13	66.64	0.52
Machinery	-	346.66	310.51	148.3	105.7	13.49
Construction In Progress	-	57.17	15.97	0.33	1.1	-

Source: S&P Capital IQ. Standard template. Financial Sources.